Olainfarm appoints new contact for investor relations – Board member Lauris Macijevskis
JSC Olainfarm hereby informs that from now on, Board Member Lauris Macijevskis will be the core contact person for shareholders and investors. His contact details are following: contact e-mail: email@example.com; contact phone: +371 29112225.
“Open and trust-based investor relations will continue to be one of the priorities of JSC Olainfarm. In our communication with shareholders we will continue to follow the principles of good governance and keep providing financial market with relevant and up-to-date information about the company's financial position and current events," informs Lauris Macijevkis.
JSC Olainfarm will continue to introduce investors to the consolidated and non-consolidated performance of the company by publishing information quarterly. The company will continue previous webinar practices, dates will be reported separately. At any other time investors are welcomed to have a dialog personally by contacting L. Macijevskis.
Previous investor Contact – person, Board Member Salvis Lapins, has terminated his working relationship with JSC Olainfarm. Salvis Lapins, who has been developing and maintaining company’s investor relations for more than 10 years, is convinced that the professional experience and competences of the new board member Lauris Macijevskis will ensure the continuity of good corporate governance practices, established at JSC Olainfarm.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company's operations is to produce reliable and effective top -quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 60 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Dana Hasana, Head of PR